Literature DB >> 24898508

[How frequently does genetic mosaicism occur in the skin?].

R Happle1.   

Abstract

BACKGROUND: Until recently, cutaneous mosaicism was considered a rare phenomenon. Its practical significance was considered minimal.
OBJECTIVES: The following questions will be considered: How often are mosaic skin disorders seen in dermatological practice? In which ways can special dermatological competence contribute to assure an appropriate genetic counseling?
METHODS: This review is based on the analysis of recent research articles and on the author's book "Mosaicism in Human Skin" (Berlin, Springer 2014).
RESULTS: The following categories can be distinguished: punctual versus disseminated mosaicism; segmental manifestation of lethal autosomal mutations; type 1 versus type 2 segmental involvement in autosomal dominant skin disorders; isolated versus superimposed manifestation of polygenic skin disorders; twin spotting; epigenetic mosaicism; revertant mosaicism.
CONCLUSIONS: Cutaneous mosaicism occurs so frequently that dermatologists can note it every day in their practice, usually in the form of punctual mosaicism. In the group of autosomal dominant genodermatoses, the type 1 segmental manifestation implies a slightly increased risk that the disorder will affect the patient's offspring in a diffuse form, whereas in cases of type 2 segmental involvement this risk is 50%. In the group of common skin disorders with a polygenic background, cellular analysis of a superimposed segmental manifestation may contribute to elucidate the genetic basis of such diseases. In the group of epigenetically controlled functional mosaics of the skin, we discriminate between X-linked and autosomal forms that are always inheritable. From the concept of revertant mosaicism, a new approach to treat severe genodermatoses can perhaps be developed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24898508     DOI: 10.1007/s00105-013-2716-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  28 in total

1.  Type 2 segmental Cowden disease vs. Proteus syndrome.

Authors:  R Happle
Journal:  Br J Dermatol       Date:  2007-03-28       Impact factor: 9.302

2.  DNA methylation profiling in X;autosome translocations supports a role for L1 repeats in the spread of X chromosome inactivation.

Authors:  Neeta Bala Tannan; Manisha Brahmachary; Paras Garg; Christelle Borel; Randah Alnefaie; Corey T Watson; N Simon Thomas; Andrew J Sharp
Journal:  Hum Mol Genet       Date:  2013-11-01       Impact factor: 6.150

3.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

4.  Molecular genetic support for the rule of dichotomy in type 2 segmental Darier disease.

Authors:  R Fölster-Holst; R G L Nellen; J-M Jensen; P Poblete-Gutiérrez; P M Steijlen; T Schwarz; R Happle; M Van Geel; J Frank
Journal:  Br J Dermatol       Date:  2012-02       Impact factor: 9.302

5.  Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin.

Authors:  R Happle
Journal:  J Am Acad Dermatol       Date:  1987-04       Impact factor: 11.527

6.  Nevus vascularis mixtus (cutaneous vascular twin nevi) associated with intracranial vascular malformation of the Dyke-Davidoff-Masson type in two patients.

Authors:  Martino Ruggieri; Pietro Milone; Piero Pavone; Raffaele Falsaperla; Agata Polizzi; Rosario Caltabiano; Marco Fichera; Anna Lia Gabriele; Angela Distefano; Rocco De Pasquale; Vincenzo Salpietro; Giuseppe Micali; Lorenzo Pavone
Journal:  Am J Med Genet A       Date:  2012-09-18       Impact factor: 2.802

7.  Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination.

Authors:  Dimitra Kiritsi; Yinghong He; Anna M G Pasmooij; Meltem Onder; Rudolf Happle; Marcel F Jonkman; Leena Bruckner-Tuderman; Cristina Has
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 8.  [Segmental type 2 manifestation of autosome dominant skin diseases. Development of a new formal genetic concept].

Authors:  R Happle
Journal:  Hautarzt       Date:  2001-04       Impact factor: 0.751

9.  Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.

Authors:  Kyle C Kurek; Valerie L Luks; Ugur M Ayturk; Ahmad I Alomari; Steven J Fishman; Samantha A Spencer; John B Mulliken; Margot E Bowen; Guilherme L Yamamoto; Harry P W Kozakewich; Matthew L Warman
Journal:  Am J Hum Genet       Date:  2012-05-31       Impact factor: 11.025

10.  Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.

Authors:  Veronica A Kinsler; Anna C Thomas; Miho Ishida; Neil W Bulstrode; Sam Loughlin; Sandra Hing; Jane Chalker; Kathryn McKenzie; Sayeda Abu-Amero; Olga Slater; Estelle Chanudet; Rodger Palmer; Deborah Morrogh; Philip Stanier; Eugene Healy; Neil J Sebire; Gudrun E Moore
Journal:  J Invest Dermatol       Date:  2013-02-07       Impact factor: 8.551

View more
  2 in total

Review 1.  [Practical aspects of molecular diagnostics in genodermatoses].

Authors:  C Has; Y He
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

2.  Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.

Authors:  K Twaroski; C Eide; M J Riddle; L Xia; C J Lees; W Chen; W Mathews; D R Keene; J A McGrath; J Tolar
Journal:  Br J Dermatol       Date:  2019-07-08       Impact factor: 9.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.